Computed Tomography Screening and Small Cell Lung Cancer Stage Shift and Survival

医学 肺癌 阶段(地层学) 回顾性队列研究 内科学 癌症登记处 肺癌筛查 肿瘤科 队列 癌症 流行病学 监测、流行病学和最终结果 队列研究 小细胞肺癌 肺 计算机断层摄影术 存活率 放射科 小细胞癌 癌症流行病学 生存分析 临床试验 入射(几何) 随机对照试验 呼吸道疾病 年轻人
作者
Alexandra L. Potter,Soneesh Kothagundla,Aniruth Ananthanarayanan,Deepti H. Srinivasan,Priyanka Senthil,Donna Tong,Timothy Hwang,George C. Linderman,Allison E.B. Chang,Lecia Van Dam Sequist,Chi‐Fu Jeffrey Yang
出处
期刊:JAMA Oncology [American Medical Association]
标识
DOI:10.1001/jamaoncol.2026.4667
摘要

Importance Lung cancer screening with low-dose computed tomography (LDCT) has been shown to identify lung cancers at earlier stages and to significantly reduce lung cancer mortality in prior randomized clinical trials. However, the benefit of LDCT screening for small cell lung cancer (SCLC), an aggressive subtype of lung cancer, is unclear. Objective To investigate the characteristics and outcomes of SCLC diagnosed after a lung cancer screening examination using a large database of Medicare beneficiaries. Design, Setting, and Participants In this retrospective cohort study, Medicare data linked to the Surveillance Epidemiology End Results Program’s cancer registry data were analyzed. Patients in the US aged 65 to 78 years who were diagnosed with SCLC from 2015 to 2021 were identified for analysis, with follow-up data through 2022. Patients who underwent 1 or more LDCT lung cancer screening examinations during the 12 months preceding their SCLC diagnosis were included in the screened group. All other patients were included in the unscreened group. Data were analyzed from January to August 2026. Exposure One or more LDCT lung cancer screenings during the 12 months preceding SCLC diagnosis. Main Outcomes and Measures The primary outcomes were stage at SCLC diagnosis and overall survival after SCLC diagnosis in the screened and unscreened groups. Results A total of 17 099 patients (median [IQR] age, 72.0 [69.0-75.0] years; 8999 [52.6%] female) met study inclusion criteria, of which 949 (5.5%) were included in the screened group and 16 150 (94.5%) were included in the unscreened group. When compared with patients in the unscreened group, patients in the screened group were significantly less likely to be diagnosed with distant disease (419 of 949 [44.2%] vs 11 376 of 16 150 [70.4%]; P < .001). Patients in the screened group also had significantly better overall survival when compared with patients in the unscreened group (3-year overall survival, 28.0% [95% CI, 24.9%-31.2%] vs 10.8% [95% CI, 10.3%-11.3%]; P < .001). Both findings were consistent in propensity score–matched analysis. Conclusions and Relevance Results of this cohort study of Medicare beneficiaries diagnosed with SCLC suggest that receipt of lung cancer screening was associated with a shift toward earlier-stage SCLC at diagnosis and improved overall survival.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
荔枝波波加油完成签到,获得积分10
1秒前
LLLight777完成签到,获得积分10
2秒前
万能图书馆的应助被Spring采纳,获得10
2秒前
3秒前
Lin发布了新的文献求助10
3秒前
3秒前
Tomsen发布了新的文献求助10
3秒前
4秒前
4秒前
DHVZA完成签到,获得积分10
5秒前
6秒前
6秒前
粱乘风发布了新的文献求助10
7秒前
JamesPei的应助被乌贼爱吃采纳,获得10
8秒前
8秒前
秋风的应助被WWW采纳,获得10
9秒前
王冬越完成签到 ,获得积分10
10秒前
桐桐的应助被落卿采纳,获得10
11秒前
yang完成签到,获得积分10
11秒前
深情安青的应助被Gp1983采纳,获得50
13秒前
加油小白完成签到 ,获得积分10
13秒前
SciGPT的应助被虚心向上采纳,获得10
13秒前
小貉完成签到,获得积分10
14秒前
15秒前
楚司遥完成签到,获得积分10
15秒前
15秒前
15秒前
良人完成签到,获得积分10
15秒前
小周爱学术完成签到,获得积分20
16秒前
顾矜的应助被喬老師采纳,获得30
16秒前
CarryLJR发布了新的文献求助10
16秒前
羊翊婕完成签到 ,获得积分10
16秒前
丿丶情殇完成签到,获得积分10
17秒前
慕雨倾欣完成签到,获得积分10
17秒前
骆十八完成签到,获得积分10
18秒前
18秒前
孑孑完成签到,获得积分10
18秒前
19秒前
21秒前
QQQ完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188563
求助须知:如何正确求助?哪些是违规求助? 9576328
关于积分的说明 21846521
捐赠科研通 7786563
什么是DOI,文献DOI怎么找? 3435354
关于科研通互助平台的介绍 2559627
邀请新用户注册赠送积分活动 2482336